Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 2/3 2Phase 4 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 3Breast Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms 1Inflammatory Breast Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Sorafenib 8Oxaliplatin 7Bevacizumab 6sintilimab 5lenvatinib 5apatinib 5Fluorouracil 5Capecitabine 5atezolizumab 4Leucovorin 4Folfox protocol 4camrelizumab 3Drug Therapy 3tremelimumab 2durvalumab 2Thalidomide 2Radiosurgery 2Nivolumab 2Neoadjuvant Therapy 2Injections 2Hepatectomy 2Gemcitabine 2Ethiodized Oil 2regorafenib 1pirarubicin 1pembrolizumab 1menatetrenone 1liposomal doxorubicin 1lanreotide 1halofantrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma, Hepatocellular × Neoadjuvant Therapy × Clear all
NCT04025437 2019-09-04

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Guangxi Medical University

Phase 2/3 Unknown
214 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02584556 2019-06-04

Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

Guangxi Medical University

Phase 2/3 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡